Please login to the form below

Not currently logged in

Perrigo appoints Gerresheimer’s Uwe Rohrhoff as CEO

He succeeds John Hendrickson, who resigns as CEO and board member

Generic pharmaceutical company Perrigo has appointed Uwe Rohrhoff, Gerresheimer’s former chief executive officer, as its new CEO.

Rohrhoff will succeed John Hendrickson, who resigns as both the Dublin-headquartered company's CEO and a member of its board.

The appointment has been one of a few changes at the company, just last year Perrigo’s chief financial officer Judy Brown stepped down from her role to join Amgen, and Ronald Winowiecki was appointed acting CFO.

Perrigo said that it suspended its search for a replacement CFO during its search for Hendrickson’s successor as CEO.

17th January 2018

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Digital health
The untapped potential to transform healthcare...
When is it time to rebrand?
The Biosimilar Challenge